Gastroparesis  >>  relamorelin (RM-131)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
relamorelin (RM-131) / AbbVie
NCT01394055: Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

Completed
1
20
US
RM-131, Placebo
Motus Therapeutics, Inc.
Diabetes Mellitus Type 1 and 2, Diabetes Mellitus Complications, Gastroparesis, Gastrointestinal Motility Disorder
11/12
12/12

Download Options